Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lannett Company Inc (NYSE:LCI)

24.00
BATS BZX Real-Time Price
As of 2:58pm ET
 +0.05 / +0.21%
Today’s Change
14.90
Today|||52-Week Range
27.90
+8.84%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$902.1M

Company Description

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products. Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations. It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.

Contact Information

Lannett Co., Inc.
9000 State Road
Philadelphia Pennsylvania 19136
P:(215) 333-9000
Investor Relations:

Employees

Shareholders

Other institutional68.46%
Individual stakeholders39.91%
Mutual fund holders35.38%

Top Executives

Arthur P. BedrosianChief Executive Officer & Director
John KozlowskiChief Operating Officer, VP-Financial Operations
Martin P. GalvanCFO, Treasurer & Vice President-Finance
Robert EhlingerChief Information Officer & VP-logistics
Kristin A. ArnoldVice President-Research & Development